Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Penas

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Neurology. Genetics|July 27, 2018
Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytomaKeren Machol, Joseph Jankovic, Dhanya Vijayakumar, et al.
Neuro-Oncology Advances|May 11, 2022
Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT)Heather E Leeper, Emily Tonorezos, Deborah Mayer, et al.
Journal of Neuro-Oncology|February 26, 2020
The prevalence of altered body image in patients with primary brain tumors: an understudied populationLindsay Rowe, Elizabeth Vera, Alvina Acquaye, et al.
Neuro-Oncology Advances|February 23, 2023
Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clusteringBrandon H Bergsneider, Elizabeth Vera, Ophir Gal, et al.
Neuro-Oncology Practice|February 7, 2025
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendationsAmanda L King, Kayla N Roche, Elizabeth Vera, et al.
Neuro-Oncology Advances|October 2, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma WorkshopMarta Penas-Prado, Brett J Theeler, Brittany Cordeiro, et al.
Frontiers in Oncology|February 6, 2023
Heterogeneous clinicopathological findings and patient-reported outcomes in adults with <i>MN1</i>-altered CNS tumors: A case report and systematic literature reviewStephen C Frederico, Elizabeth Vera, Zied Abdullaev, et al.
Neuro-Oncology Practice|November 17, 2022
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patientsAmanda L King, Dorela D Shuboni-Mulligan, Elizabeth Vera, et al.
Cancer|October 26, 2018
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastomaStefania Maraka, Morris D Groves, Aaron G Mammoser, et al.
Journal of Neuro-Oncology|February 7, 2018
NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patientsArif N Ali, Peixin Zhang, W K Alfred Yung, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Neurology. Genetics|July 27, 2018
Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytomaKeren Machol, Joseph Jankovic, Dhanya Vijayakumar, et al.
Neuro-Oncology Advances|May 11, 2022
Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT)Heather E Leeper, Emily Tonorezos, Deborah Mayer, et al.
Journal of Neuro-Oncology|February 26, 2020
The prevalence of altered body image in patients with primary brain tumors: an understudied populationLindsay Rowe, Elizabeth Vera, Alvina Acquaye, et al.
Neuro-Oncology Advances|February 23, 2023
Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clusteringBrandon H Bergsneider, Elizabeth Vera, Ophir Gal, et al.
Neuro-Oncology Practice|February 7, 2025
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendationsAmanda L King, Kayla N Roche, Elizabeth Vera, et al.
Neuro-Oncology Advances|October 2, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma WorkshopMarta Penas-Prado, Brett J Theeler, Brittany Cordeiro, et al.
Frontiers in Oncology|February 6, 2023
Heterogeneous clinicopathological findings and patient-reported outcomes in adults with <i>MN1</i>-altered CNS tumors: A case report and systematic literature reviewStephen C Frederico, Elizabeth Vera, Zied Abdullaev, et al.
Neuro-Oncology Practice|November 17, 2022
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patientsAmanda L King, Dorela D Shuboni-Mulligan, Elizabeth Vera, et al.
Cancer|October 26, 2018
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastomaStefania Maraka, Morris D Groves, Aaron G Mammoser, et al.
Journal of Neuro-Oncology|February 7, 2018
NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patientsArif N Ali, Peixin Zhang, W K Alfred Yung, et al.
Pageof 11